EDITAS MEDICINE, INC. Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2024-09-30 was $0.00.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2024-06-30 was $0.00.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2024-03-31 was $0.00.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2023-09-30 was $0.00.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2018 was $4.00K, a 99.90% decline from fiscal 2017.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2017 was $4.10M, a 37136.36% increase from fiscal 2016.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2016 was $11.00K, a 35.29% decline from fiscal 2015.
- EDITAS MEDICINE, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2015 was $17.00K, a 750.00% increase from fiscal 2014.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3 month | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 12 month |
|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-11-04 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-11-04 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-11-04 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-11-03 | |
| 2019-06-30 | $410.00K 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $410.00K 10-Q · filed 2019-08-07 | |
| 2018-12-31 | $4.00K 10-K · filed 2019-03-01 | |
| 2018-06-30 | $677.00K 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $652.00K 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $4.10M 10-K · filed 2019-03-01 | |
| 2016-12-31 | $11.00K 10-K · filed 2019-03-01 | |
| 2015-12-31 | $17.00K 10-K · filed 2018-03-08 | |
| 2014-12-31 | $2.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |